Related Experiment Videos
A gene-targeted mouse model for chorea-acanthocytosis
Yuko Tomemori1, Mio Ichiba, Akira Kusumoto
1Department of Psychiatry, Kagoshima University Graduate School of Medical and Ental Sciences, Kagoshima, Japan.
Journal of Neurochemistry
|February 3, 2005
Summary
Researchers developed a mouse model for chorea-acanthocytosis (CHAC), a rare neurodegenerative disease. This model exhibits key symptoms like acanthocytosis and motor deficits, aiding in understanding human CHAC progression.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Chorea-acanthocytosis (CHAC) is an autosomal recessive neurodegenerative disorder.
- It presents with Huntington's disease-like symptoms and acanthocytosis (abnormal red blood cells).
- The CHAC gene, encoding chorein, was recently identified, with mutations found in affected families.
Purpose of the Study:
- To create and characterize a mouse model for chorea-acanthocytosis (CHAC).
- To investigate the neurological and pathological features of the CHAC mouse model.
- To validate the utility of this model for studying human CHAC.
Main Methods:
- Identified mouse CHAC cDNA sequence and gene structure.
- Generated a CHAC model mouse using gene-targeting with a specific exon deletion.
- Performed behavioral tests, brain pathology analysis, and neurochemical determinations.
Main Results:
- CHAC model mice developed acanthocytosis and motor disturbances in old age.
- Reduced locomotor activity and social interaction were observed in mutant mice.
- Brain pathology revealed striatal apoptosis, and decreased dopamine metabolite (homovanillic acid) levels.
Conclusions:
- The CHAC model mouse exhibits a mild phenotype with late-onset symptoms, mirroring human CHAC.
- This model provides a valuable system for studying the pathogenesis of chorea-acanthocytosis.
- Findings support the relevance of the identified gene mutation and its pathological consequences.